Loading...
530999 logo

Balaji Amines LimitedBSE:530999 Aktienübersicht

Marktkapitalisierung ₹43.2b
Aktienkurs
₹1.33k
₹1.45k
8.0% unterbewertet intrinsischer Abschlag
1Y5.2%
7D7.3%
Wert des Portfolios
​
Siehe

Balaji Amines Limited

BSE:530999 Lagerbericht

Marktkapitalisierung: ₹43.2b

Balaji Amines (530999) Aktienübersicht

Balaji Amines Limited beschäftigt sich mit der Herstellung und dem Verkauf von Methylaminen, Ethylaminen und Derivaten von Spezialchemikalien und pharmazeutischen Hilfsstoffen in Indien. Mehr Details

530999 grundlegende Analyse
Schneeflocken-Punktzahl
Bewertung1/6
Künftiges Wachstum4/6
Vergangene Leistung1/6
Finanzielle Gesundheit6/6
Dividenden4/6

Belohnungen

Prognostiziertes Gewinnwachstum 27.53% pro Jahr

Risikoanalyse

Dividende von 0.83% ist nicht gut durch freie Cashflows gedeckt


530999 Community Fair Values

Create Narrative

See what 9 others think this stock is worth. Follow their fair value or set your own to get alerts.

Analyst Price Targets

View all narratives
UG logo
UGFeatured

An Undervalued 3.3Moz Gold Project in Canada

Key takeaways Upside Gold is developing the Kena Gold Project, near the town of Nelson in the Kootenays region of southern British Columbia. Kena hosts a historical gold resource of 3.33 million ounces (561,000 ounces Indicated and 2.77 million ounces Inferred) across a 10,200-hectare land package.
View narrative
Community Contributor
CA$5.07FV • 68.6% unterbewertet intrinsischer Abschlag
4849.4%Revenue growth p.a.
13.3k
37
1
270
2mo ago

Balaji Amines Limited Wettbewerber

Preisentwicklung & Leistung

Zusammenfassung der Höchst- und Tiefststände sowie der Veränderungen der Aktienkurse für Balaji Amines
Historische Aktienkurse
Aktueller Aktienkurs₹1,331.85
52-Wochen-Hoch₹1,946.00
52-Wochen-Tief₹905.15
Beta0.44
1 Monat Veränderung36.32%
3 Monate Veränderung19.15%
1 Jahr Veränderung5.18%
3 Jahre Veränderung-41.81%
5 Jahre Veränderung-46.42%
Veränderung seit IPO10,525.05%

Aktuelle Nachrichten und Updates

530999: Higher Revenue Outlook And Lean Margins Will Support Future Upside

Analysts have trimmed their price target for Balaji Amines from ₹1,616.67 to ₹1,447.50, reflecting updated assumptions around discount rate, revenue growth, profit margin, and future P/E. Valuation Changes Fair Value: Trimmed from ₹1,616.67 to ₹1,447.50, indicating a lower central estimate for the share price.

530999: Higher Margin Outlook And Upcoming Results Will Support Bullish Repricing

Analysts have kept the price target for Balaji Amines steady at ₹1,561, citing slightly adjusted assumptions on the discount rate, revenue growth, profit margin and forward P/E as the main factors behind the unchanged view. What's in the News A board meeting is scheduled for January 29, 2026 to consider and approve the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025 (Key Developments).

530999: Refined Margins And P E Assumptions Will Likely Support Returns

Analysts have maintained their fair value estimate for Balaji Amines at ₹1,334. The steady price target is supported by only small adjustments to the discount rate, revenue growth assumptions, profit margin and future P/E expectations.

530999: Refined Margins And P E Assumptions Will Likely Support Returns

Analysts have kept their fair value estimate for Balaji Amines steady at ₹1,334, with small refinements to the discount rate, revenue growth, profit margin and future P/E assumptions guiding this unchanged price target. What's in the News A board meeting is scheduled on Jan 29, 2026 to consider, approve and take on record the unaudited standalone and consolidated financial results for the quarter and nine months ended Dec 31, 2025 (company filing).

530999: Higher Future P E And Margins Will Likely Support Returns

Analysts have maintained their price target for Balaji Amines at ₹1,334, reflecting a balance between a lower discount rate, slightly adjusted revenue growth assumptions, a modestly higher profit margin outlook, and a marginally higher future P/E multiple. What's in the News Board meeting scheduled for January 29, 2026, to review and approve the unaudited standalone financial results for the quarter and nine months ended December 31, 2025.

530999: Higher Margin Outlook And Upcoming Results Will Support Bullish Repricing

Analysts have revised their price target for Balaji Amines from ₹2,331 to ₹1,561, reflecting updated views on a lower assumed revenue growth rate, a slightly higher discount rate, a higher profit margin, and a reduced future P/E multiple. What's in the News Board meeting scheduled for Jan 29, 2026, to review and approve the unaudited standalone financial results for the quarter and nine months ended Dec 31, 2025 (Key Developments).

Recent updates

530999: Higher Revenue Outlook And Lean Margins Will Support Future Upside

Analysts have trimmed their price target for Balaji Amines from ₹1,616.67 to ₹1,447.50, reflecting updated assumptions around discount rate, revenue growth, profit margin, and future P/E. Valuation Changes Fair Value: Trimmed from ₹1,616.67 to ₹1,447.50, indicating a lower central estimate for the share price.

530999: Higher Margin Outlook And Upcoming Results Will Support Bullish Repricing

Analysts have kept the price target for Balaji Amines steady at ₹1,561, citing slightly adjusted assumptions on the discount rate, revenue growth, profit margin and forward P/E as the main factors behind the unchanged view. What's in the News A board meeting is scheduled for January 29, 2026 to consider and approve the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025 (Key Developments).

530999: Refined Margins And P E Assumptions Will Likely Support Returns

Analysts have maintained their fair value estimate for Balaji Amines at ₹1,334. The steady price target is supported by only small adjustments to the discount rate, revenue growth assumptions, profit margin and future P/E expectations.

530999: Refined Margins And P E Assumptions Will Likely Support Returns

Analysts have kept their fair value estimate for Balaji Amines steady at ₹1,334, with small refinements to the discount rate, revenue growth, profit margin and future P/E assumptions guiding this unchanged price target. What's in the News A board meeting is scheduled on Jan 29, 2026 to consider, approve and take on record the unaudited standalone and consolidated financial results for the quarter and nine months ended Dec 31, 2025 (company filing).

530999: Higher Future P E And Margins Will Likely Support Returns

Analysts have maintained their price target for Balaji Amines at ₹1,334, reflecting a balance between a lower discount rate, slightly adjusted revenue growth assumptions, a modestly higher profit margin outlook, and a marginally higher future P/E multiple. What's in the News Board meeting scheduled for January 29, 2026, to review and approve the unaudited standalone financial results for the quarter and nine months ended December 31, 2025.

530999: Higher Margin Outlook And Upcoming Results Will Support Bullish Repricing

Analysts have revised their price target for Balaji Amines from ₹2,331 to ₹1,561, reflecting updated views on a lower assumed revenue growth rate, a slightly higher discount rate, a higher profit margin, and a reduced future P/E multiple. What's in the News Board meeting scheduled for Jan 29, 2026, to review and approve the unaudited standalone financial results for the quarter and nine months ended Dec 31, 2025 (Key Developments).

530999: Richer Forward P/E Will Likely Support Returns Despite Thinner Margins

Analysts have raised their price target for Balaji Amines from ₹1,185 to ₹1,334, reflecting revised assumptions of higher revenue growth and a richer forward P/E multiple, partly offset by a lower profit margin outlook and a slightly higher discount rate. What's in the News Board meeting scheduled on Jan 29, 2026, to consider, approve and take on record the unaudited standalone and consolidated financial results for the quarter and nine months ended Dec 31, 2025 (company filing).

530999: Stable Margins And Upcoming Results Will Support Further Upside

Analysts have maintained their price target for Balaji Amines at ₹1,616.67, reflecting largely unchanged assumptions on the discount rate, revenue growth, profit margin and future P/E. What's in the News A board meeting is scheduled for November 10, 2025, to consider and approve the unaudited standalone financial results for the quarter and half year ended September 30, 2025 (company filing).

530999 Will Likely See Slower Expansion Offset By Stronger Profit Margins

Analysts have reduced their fair value estimate for Balaji Amines to ₹1,185 from ₹1,598, citing expectations of slower revenue growth and a lower future P E multiple. This is partially offset by improved projected profit margins and a slightly higher discount rate.

530999: Stable Margins And Growth Outlook Will Support Further Upside

Analysts have modestly lifted their price target on Balaji Amines to ₹1,616.67 per share, reflecting slightly higher assumed discount rates and steady long term growth and margin expectations that together support a marginally richer valuation multiple. What's in the News Board meeting scheduled on November 10, 2025 to consider and approve unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025 (company filing).

530999: Rising Profit Margins Will Drive Further Upside Despite Slower Sales

Analysts have revised their price target for Balaji Amines downward from ₹1,847 to ₹1,617. This change is due to expectations of slower revenue growth, even though profit margin projections have improved.

New Plant Launches And Certifications Set To Drive Future Operational Efficiency And Revenue Potential

With both the Future P/E and Discount Rate showing only marginal changes, analysts have effectively maintained their valuation outlook for Balaji Amines, resulting in an unchanged consensus price target of ₹1847. What's in the News Board meeting scheduled to consider and approve un-audited standalone and consolidated financial results for the quarter ended 30 June 2025.
User avatar

New Plant Launches And Certifications Set To Drive Future Operational Efficiency And Revenue Potential

New plant expansions and strategic focus on high-margin products promise revenue growth and improved net margins through enhanced efficiency and diversification.

Aktionärsrenditen

530999IN ChemicalsIN Markt
7D7.3%-0.3%-0.7%
1Y5.2%-1.5%3.9%

Rendite im Vergleich zur Industrie: 530999 übertraf die Branche Indian Chemicals , die im vergangenen Jahr eine Rendite von -1.5 erzielte.

Rendite vs. Markt: 530999 entspricht dem Indian Markt, der im vergangenen Jahr eine Rendite von 3.9 erzielte.

Preisvolatilität

Is 530999's price volatile compared to industry and market?
530999 volatility
530999 Average Weekly Movement6.1%
Chemicals Industry Average Movement7.1%
Market Average Movement7.2%
10% most volatile stocks in IN Market10.2%
10% least volatile stocks in IN Market4.7%

Stabiler Aktienkurs: 530999 hatte in den letzten 3 Monaten im Vergleich zum Indian -Markt keine signifikante Preisvolatilität.

Volatilität im Zeitverlauf: 530999Die wöchentliche Volatilität (6%) ist im vergangenen Jahr stabil geblieben.

Über das Unternehmen

GegründetMitarbeiterCEOWebsite
19881,169Dundurapu Reddywww.balajiamines.com

Balaji Amines Limited beschäftigt sich mit der Herstellung und dem Verkauf von Methylaminen, Ethylaminen und Derivaten von Spezialchemikalien und pharmazeutischen Hilfsstoffen in Indien. Das Unternehmen ist in zwei Segmenten tätig: Chemie und Hotel. Es bietet Monomethylamin, Dimethylamin, Trimethylamin, Monoethylamin, Diethylamin, Triethylamin sowie Dimethyl- und Diethylaminoethanol und Spezialchemikalien, darunter N-Methylpyrrolidon, Morpholin, 2-Pyrrolidon, N-Ethyl-2-Pyrrolidon, Gamma-Butyrolacton, Dimethylformamid, Acetonitril, Dimethylcarbonat, Propylenglykol und Propylencarbonat.

Balaji Amines Limited's Grundlagenzusammenfassung

Wie verhalten sich die Erträge und Einnahmen von Balaji Amines im Vergleich zum Marktanteil des Unternehmens?
530999 grundlegende Statistiken
Marktanteil₹43.15b
Gewinn(TTM)₹1.44b
Umsatz(TTM)₹13.83b
30.0x
Kurs-Gewinn-Verhältnis
3.1x
Kurs-Umsatz-Verhältnis

Ist 530999 zu teuer?

Siehe Fair Value und Bewertungsanalyse

Erträge & Einnahmen

Wichtige Rentabilitätsstatistiken aus dem letzten Ergebnisbericht (TTM)
530999 Gewinn- und Verlustrechnung (TTM)
Einnahmen₹13.83b
Kosten der Einnahmen₹7.83b
Bruttogewinn₹6.00b
Sonstige Ausgaben₹4.56b
Gewinn₹1.44b

Zuletzt gemeldete Gewinne

Dec 31, 2025

Datum des nächsten Gewinnberichts

k.A.

Gewinn per Aktie (EPS)44.46
Bruttomarge43.38%
Nettogewinnspanne10.42%
Schulden/Eigenkapital-Verhältnis1.5%

Wie hat sich 530999 auf lange Sicht entwickelt?

Historische Performance und Vergleiche

Dividenden

0.8%
Aktuelle Dividendenrendite
23%
Ausschüttungsquote

Unternehmensanalyse und Finanzdaten Status

DatenZuletzt aktualisiert (UTC-Zeit)
Unternehmensanalyse2026/04/30 10:29
Aktienkurs zum Tagesende2026/04/30 00:00
Gewinne2025/12/31
Jährliche Einnahmen2025/03/31

Datenquellen

Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.

PaketDatenZeitrahmenBeispiel US-Quelle *
Finanzdaten des Unternehmens10 Jahre
  • Gewinn- und Verlustrechnung
  • Kapitalflussrechnung
  • Bilanz
Konsensschätzungen der Analysten+3 Jahre
  • Finanzielle Vorausschau
  • Kursziele der Analysten
Marktpreise30 Jahre
  • Aktienkurse
  • Dividenden, Splits und Aktionen
Eigentümerschaft10 Jahre
  • Top-Aktionäre
  • Insiderhandel
Verwaltung10 Jahre
  • Das Führungsteam
  • Direktorium
Wichtige Entwicklungen10 Jahre
  • Ankündigungen des Unternehmens

* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.

Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.

Analysemodell und Schneeflocke

Einzelheiten zu dem Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite. Außerdem bieten wir Leitfäden zur Verwendung unserer Berichte und Tutorials auf YouTube an.

Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.

Metriken für Industrie und Sektor

Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.

Analysten-Quellen

Balaji Amines Limited wird von 3 Analysten beobachtet. 2 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.

AnalystEinrichtung
Nilesh GhugeHDFC Securities Limited
Jay GandhiHDFC Securities Limited
null nullK.R. Choksey Shares & Securities Private Ltd.